Back to search

Switzerland· 61893002

Trajenta, Filmtabletten

A linagliptin product containing linagliptinum, registered in Switzerland by Boehringer Ingelheim (Schweiz) GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A10BH05

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedTrajenta, FilmtablettenATCA10BH05REGISTER NO.61893002PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Linagliptin is registered in 17 of 19 countries.

Countries holding a registration under ATC A10BH05 (linagliptin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Linagliptin · ATC A10BH05

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of linagliptin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.

  • Switzerland: $2.05 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Linagliptin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • IT Italy$2.52
  • CH Switzerland$2.05
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
linagliptinum
Manufacturer
Boehringer Ingelheim (Schweiz) GmbH
Country
Switzerland (CH)
ATC code
A10BH05
ATC class
Linagliptin
Defined daily dose
5 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680618930024
    90 Stk
    CHF 136.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

373 interactions on record for linagliptin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Linagliptin · interactions on record

373 records

  • 3 severe
  • 330 moderate
  • 40 minor

Most severe, free to view

  • GatifloxacinJ01MA16severe
  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Linagliptin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All linagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Ilinpru, Liamell
  • Belgium · Linagliptin Eg, Linagliptin Eg (Eurogenerics) Nv
  • Bulgaria · Linagliptin Accord, Глунава
  • Cyprus · Glunava, Linagliptin Accord
  • Czechia · Glunava, Jeligo
  • Germany · Linagliptin Abdi
  • Denmark · Linagliptin "pharmapath", Linagliptin Accord
  • Estonia · Glunava, Linagliptin Accord
  • Spain · Donumid, Ilinpru
  • Finland · Linagliptin Accord, Linagliptin Advanz Pharma
  • France · Linagliptine Zentiva
  • United Kingdom (Northern Ireland) · Linagliptin, Linagliptin Altair Science
  • Greece · Bottiar, Drojarto
  • Croatia · Larida, Liglinra
  • Hungary · Ilinpru, Jeligo
  • Ireland · Linagliptin Accord, Linagliptin Clonmel
  • Iceland · Linagliptin Krka, Linagliptin Stada
  • Italy · Linagliptin Abdi, Linagliptin Aurobindo
  • Liechtenstein · Trajenta
  • Lithuania · Bottiar, Jeligo
  • Luxembourg · Linagliptin Eg
  • Latvia · Linagliptin Accord, Linagliptin Olpha
  • Malta · Liamell, Linagliptin
  • Netherlands · Linagliptin Viatris, Linagliptin Vivanta
  • Norway · Linagliptin Accord, Linagliptin Krka
  • Poland · Jeligo, Larida
  • Portugal · Enanta, Larida
  • Romania · Jeligo, Linagliptin Medochemie
  • Sweden · Liglinra, Linagliptin Accord
  • Slovenia · Liglipex, Linagliptin Krka
  • Slovakia · Glunava, Ilinpru

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a842aa40-8dac-446b-b3be-5eee1a4269c4
GET /v1/drugs/a842aa40-8dac-446b-b3be-5eee1a4269c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "linagliptinum 5 mg",
  "valid_from": "2012-05-01",
  "limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, welche mit Diät, körperlicher Bewegung und den bisherigen oralen Therapien nur ungenügend eingestellt werden können oder diese nicht vertragen.<br>\\n- Als Monotherapie, bei Patienten mit einer Unverträglichkeit oder Kontraindikation für Metformin.<br>\\n- Als Zweifachkombination ausschliesslich mit Metformin oder einem Sulfonylharnstoff oder einem Thia-zolidindion, wenn mit diesen Behandlungen keine ausreichende Kontrolle der Glykämie erreicht werden kann.<br>\\n- Als Dreifachkombination mit Metformin und einem Sulfonylharnstoff, wenn durch diese oralen Antidiabetika keine ausreichende Kontrolle der Glykämie erreicht wird.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2023-12-01\"}]",
  "galenic_form": "Filmtabl 5 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2012-05-01",
  "self_retention_pct": 10
}

See everything about linagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.